UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 99

Sortiert nach

Hematologic Malignancies in Pregnancy: Management Guidelines From an International Consensus Meeting

Journal of clinical oncology, 2016-02, Vol.34 (5), p.501-508

2016

Volltextzugriff (PDF)

A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients

PloS one, 2017-03, Vol.12 (3), p.e0172799-e0172799

2017

Volltextzugriff (PDF)

Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival

PloS one, 2017-08, Vol.12 (8), p.e0181615-e0181615

2017

Volltextzugriff (PDF)

MicroRNA-192-5p is a predictive biomarker of survival for Stage IIIB colon cancer patients

Japanese journal of clinical oncology, 2018-07, Vol.48 (7), p.619-624

2018

Volltextzugriff (PDF)

Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells

Oncoimmunology, 2018-09, Vol.7 (9), p.e1472195-e1472195

2018

Volltextzugriff (PDF)

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

The Lancet (British edition), 2019-05, Vol.393 (10184), p.1948-1957

2019

Volltextzugriff (PDF)

T cell-recruiting triplebody 19-3-19 mediates serial lysis of malignant B-lymphoid cells by a single T cell

Oncotarget, 2014-08, Vol.5 (15), p.6466-6483

2014

Volltextzugriff (PDF)

A recombinant triplebody with specificity for CD19 and HLA-DR mediates  preferential binding to antigen double-positive cells by dual-targeting

mAbs, 2012-01, Vol.4 (1), p.45-56

2012

Volltextzugriff (PDF)

The ethics of deep brain stimulation (DBS)

Medicine, health care, and philosophy, 2015-11, Vol.18 (4), p.475-485

2015

Volltextzugriff (PDF)

Association between Ki67 Index and Clinicopathological Features in Colorectal Cancer

Oncology research and treatment, 2016-11, Vol.39 (11), p.696-702

2016

Volltextzugriff (PDF)

Priority-setting, rationing and cost-effectiveness in the German health care system

Medicine, health care, and philosophy, 2013-08, Vol.16 (3), p.327-339

Oduncu, Fuat S.

2013

Volltextzugriff (PDF)

The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance

Acta oncologica, 2016-01, Vol.55 (3), p.318-328

2016

Volltextzugriff (PDF)

Phage idiotype vaccination: first phase I/II clinical trial in patients with multiple myeloma

Journal of translational medicine, 2014-05, Vol.12 (1), p.119-119, Article 119

2014

Volltextzugriff (PDF)

Dual-targeting triplebody 33-3-19 mediates selective lysis of biphenotypic CD19+ CD33+ leukemia cells

Oncotarget, 2016-04, Vol.7 (16), p.22579-22589

2016

Volltextzugriff (PDF)

A dual-targeting triplebody mediates preferential redirected lysis of antigen double-positive over single-positive leukemic cells

mAbs, 2014-01, Vol.6 (1), p.286-296

2014

Volltextzugriff (PDF)

Chip-based platform for dynamic analysis of NK cell cytolysis mediated by a triplebody

Analyst (London), 2016-04, Vol.141 (7), p.2284-2295

2016

Volltextzugriff (PDF)

ITOC2 – 024. Selective lysis of biphenotypic leukaemia cells is mediated by dual-targeting triplebody 33-3-19 treatment

European journal of cancer (1990), 2015-03, Vol.51, p.S9-S9

2015

Volltextzugriff (PDF)

Evidence for an Association of ERCC1 Expression and Mismatch Repair Status with Overall Survival in Colorectal Cancer Patients

Oncology research and treatment, 2017, Vol.40 (11), p.702-706

2017

Volltextzugriff (PDF)

Doctor-cared dying instead of physician-assisted suicide: a perspective from Germany

Medicine, health care, and philosophy, 2010-11, Vol.13 (4), p.371-381

2010

Volltextzugriff (PDF)

NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM-2

Journal of translational medicine, 2013-11, Vol.11 (1), p.289-289

2013

Volltextzugriff (PDF)

Incidence and risk factors of bisphosphonate-related osteonecrosis of the jaw in multiple myeloma patients having undergone autologous stem cell transplantation

Onkologie, 2012-11, Vol.35 (11), p.658-664

2012

Volltextzugriff (PDF)

Impact of age and mismatch repair status on survival in colorectal cancer

Cancer medicine (Malden, MA), 2017-05, Vol.6 (5), p.975-981

2017

Volltextzugriff (PDF)

CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cells

Oncotarget, 2016-12, Vol.7 (50), p.83392-83408

2016

Volltextzugriff (PDF)

Perspectives on assisted dying

Medicine, health care, and philosophy, 2010-11, Vol.13 (4), p.351-353

2010

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(74)
Deutsch
(23)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Humans
(52)
Science & Technology
(47)
Life Sciences & Biomedicine
(44)
Oncology
(28)
Female
(21)
Male
(18)
Hematology
(16)
Adult
(14)
Aged
(14)
Middle Aged
(14)
Multiple Myeloma
(14)
Antineoplastic Agents - Pharmacology
(10)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Prognosis
(10)
Animals
(9)
Apoptosis - Drug Effects
(9)
Medicine, Research & Experimental
(8)
Neoplasm Staging
(8)
Research & Experimental Medicine
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Hematologic Malignancies in Pregnancy: Management Guidelines From an International Consensus Meeting

A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients

Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival

MicroRNA-192-5p is a predictive biomarker of survival for Stage IIIB colon cancer patients

Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group

T cell-recruiting triplebody 19-3-19 mediates serial lysis of malignant B-lymphoid cells by a single T cell

A recombinant triplebody with specificity for CD19 and HLA-DR mediates  preferential binding to antigen double-positive cells by dual-targeting

The ethics of deep brain stimulation (DBS)

Association between Ki67 Index and Clinicopathological Features in Colorectal Cancer

Priority-setting, rationing and cost-effectiveness in the German health care system

The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance

Phage idiotype vaccination: first phase I/II clinical trial in patients with multiple myeloma

Dual-targeting triplebody 33-3-19 mediates selective lysis of biphenotypic CD19+ CD33+ leukemia cells

A dual-targeting triplebody mediates preferential redirected lysis of antigen double-positive over single-positive leukemic cells

Chip-based platform for dynamic analysis of NK cell cytolysis mediated by a triplebody

ITOC2 – 024. Selective lysis of biphenotypic leukaemia cells is mediated by dual-targeting triplebody 33-3-19 treatment

Evidence for an Association of ERCC1 Expression and Mismatch Repair Status with Overall Survival in Colorectal Cancer Patients

Doctor-cared dying instead of physician-assisted suicide: a perspective from Germany

NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM-2

Incidence and risk factors of bisphosphonate-related osteonecrosis of the jaw in multiple myeloma patients having undergone autologous stem cell transplantation

Impact of age and mismatch repair status on survival in colorectal cancer

CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cells

Perspectives on assisted dying

Suchergebnisse filtern